Neufeld Leah R — SEC Form 4 filings
SEC reporting owner CIK 1950673. 10 Form 4 filings on record with FilingPulse; latest filed 2026-03-17.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-09 to 2026-03-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 4 filings — 7,944 shares, $29,501 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 3,818 shares @ $2.88 ($10,993) in Immuneering Corp, filed 2024-03-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Immuneering Corp (IMRX) | CHIEF PEOPLE OFFICER | 10 | 4 legs · 7,944 sh · $29,501 | — | 12 |
Form 4 filings — Neufeld Leah R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-17 | 4 | Immuneering Corp (IMRX) | Grant/award (A): 3,628 @ $4.29 | EDGAR |
| 2026-02-05 | 4 | Immuneering Corp (IMRX) | Grant/award (A): 140,000 (derivative) @ $0 | EDGAR |
| 2026-01-15 | 4 | Immuneering Corp (IMRX) | Purchase (P): 2,626 @ $4.15 | EDGAR |
| 2025-10-02 | 4 | Immuneering Corp (IMRX) | Purchase (P): 800 @ $6.38 | EDGAR |
| 2025-09-17 | 4 | Immuneering Corp (IMRX) | Grant/award (A): 11,815 @ $1.43 | EDGAR |
| 2025-07-07 | 4 | Immuneering Corp (IMRX) | Purchase (P): 700 @ $3.57 | EDGAR |
| 2025-02-07 | 4 | Immuneering Corp (IMRX) | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | Immuneering Corp (IMRX) | Disposition to issuer (D): 88,600 (derivative) @ $0 · Grant/award (A): 88,600 (derivative) @ $0 · Disposition to issuer (D): 105,000 (derivative) @ $0 · Grant/award (A): 105,000 (derivative) @ $0 · Disposition to issuer (D): 60,500 (derivative) @ $0 · Grant/award (A): 60,500 (derivative) @ $0 | EDGAR |
| 2024-03-21 | 4 | Immuneering Corp (IMRX) | Grant/award (A): 6,211 @ $1.62 · Purchase (P): 3,818 @ $2.88 | EDGAR |
| 2024-02-09 | 4 | Immuneering Corp (IMRX) | Grant/award (A): 60,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1950673 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →